These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12528318)

  • 1. Side effects of statins--prevalence, relevance, consequences.
    Sinzinger H
    Wien Klin Wochenschr; 2002 Nov; 114(21-22):887-8. PubMed ID: 12528318
    [No Abstract]   [Full Text] [Related]  

  • 2. Experts confirm statins' safety but advise caution with certain patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Jul; 13(13):1-2, 5. PubMed ID: 12515256
    [No Abstract]   [Full Text] [Related]  

  • 3. [HMG-CoA reductase inhibitors and sexual dysfunction].
    Pía Iglesias G; Fernández Fernández FJ; Ameneiros Lago E; Sesma Sánchez P
    An Med Interna; 2001 Mar; 18(3):171. PubMed ID: 11594194
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
    Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
    Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myopathy due to statins, a dose-dependent effect, and of what kind?].
    León Vázquez F; Llanes De Torres R; Morón Merchante I
    Aten Primaria; 2002; 30(3):188. PubMed ID: 12139858
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antilipemic therapy and rhabdomyolysis].
    Paragh G; Balogh Z; Romics L
    Orv Hetil; 2003 Mar; 144(11):515-20. PubMed ID: 12731338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
    Landesman KA; Stozek M; Freeman NJ
    Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin myopathy: the iceberg or its tip?
    Campbell WW
    Muscle Nerve; 2006 Oct; 34(4):387-90. PubMed ID: 16810688
    [No Abstract]   [Full Text] [Related]  

  • 9. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
    Koro CE; Sowell MO; Stender M; Qizilbash N
    Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Statins and neuromuscular pathology].
    Turpin-Fenoll L; Millan-Pascual J; Martin-Estefania C
    Rev Neurol; 2008 Jul 1-15; 47(1):46-51. PubMed ID: 18592480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayer pulls cerivastatin (Baycol) from market.
    Wooltorton E
    CMAJ; 2001 Sep; 165(5):632. PubMed ID: 11563216
    [No Abstract]   [Full Text] [Related]  

  • 12. Baycol withdrawn from market.
    SoRelle R
    Circulation; 2001 Aug; 104(8):E9015-6. PubMed ID: 11521677
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and statin therapy: reconsidering the risks and benefits.
    Gotto AM
    Arch Intern Med; 2003 Mar; 163(6):657-9. PubMed ID: 12639194
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential adverse effects of statins on muscle.
    Tomlinson SS; Mangione KK
    Phys Ther; 2005 May; 85(5):459-65. PubMed ID: 15842193
    [No Abstract]   [Full Text] [Related]  

  • 15. [We, the Italian physicians, and statins].
    Bobbio M
    Ital Heart J Suppl; 2001 Nov; 2(11):1149-54. PubMed ID: 11775405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibitor-induced impotence.
    Halkin A; Lossos IS; Mevorach D
    Ann Pharmacother; 1996 Feb; 30(2):192. PubMed ID: 8835058
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of statin therapy in patients with preexisting liver disease.
    Onofrei MD; Butler KL; Fuke DC; Miller HB
    Pharmacotherapy; 2008 Apr; 28(4):522-9. PubMed ID: 18363535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscular adverse effects of statins.
    Prescrire Int; 2003 Feb; 12(63):21. PubMed ID: 12602397
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid-lowering therapy--benefits and risks.
    Abinader EG
    Isr Med Assoc J; 2007 Feb; 9(2):132-3; author reply 133-4. PubMed ID: 17354321
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid-lowering therapy--benefits and risks.
    Shechter M
    Isr Med Assoc J; 2007 Feb; 9(2):133; author reply 133-4. PubMed ID: 17348492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.